NOPE (Nucleolar protein 3), although not a widely recognized protein in mainstream biochemical research, plays a crucial role in the intricate machinery of cellular processes. This protein, localized primarily within the nucleolus, participates in the regulation of ribosome biogenesis-a critical step in cellular protein synthesis. The nucleolus is the cellular hub for the synthesis and assembly of ribosomal subunits, and proteins like NOPE are pivotal in coordinating the complex interactions that facilitate these processes. Additionally, NOPE is involved in various other cellular mechanisms, including the cell cycle regulation and stress response pathways. Its function underscores the nuanced balance within cellular homeostasis, where the precise regulation of protein synthesis is paramount for growth, proliferation, and survival.
The inhibition of NOPE revolves around disrupting its normal biological functions, thereby potentially affecting ribosome biogenesis and other related cellular processes. Inhibition strategies target the specific interactions or pathways NOPE is involved in, aiming to modulate its activity within the cell. This can be achieved through various molecular mechanisms, including but not limited to, the direct binding of inhibitors to NOPE, affecting its stability or altering its interaction with other nucleolar proteins. Additionally, inhibiting NOPE might involve the suppression of its expression levels through the interference with transcriptional or translational mechanisms. Since NOPE plays a role in critical cellular functions, its inhibition could lead to a cascade of effects on cell growth, proliferation, and survival, highlighting the complex interplay between protein synthesis regulation and cellular homeostasis. The nuanced approach to inhibiting NOPE requires a deep understanding of its role within the nucleolus and the broader context of its involvement in cellular physiology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-specific inhibitor of phosphodiesterases, increases intracellular cAMP levels, indirectly affecting signaling pathways that could intersect with IGDCC4's role. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, affects cell shape, motility, and possibly adhesion by modulating actin cytoskeleton dynamics, potentially intersecting with IGDCC4-related pathways. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits TGF-beta type I receptor, altering signaling pathways involved in cell proliferation, differentiation, and development, possibly affecting IGDCC4's regulatory mechanisms. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
A gamma-secretase inhibitor, affects Notch signaling, potentially influencing cellular differentiation and neurite outgrowth, processes where IGDCC4 might play a role. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, affecting MAPK/ERK pathway, potentially modulating cellular responses involved in growth, differentiation, and possibly intersecting with IGDCC4's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, affects cell survival, growth, and migration pathways, potentially influencing processes related to IGDCC4's role in cell communication. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor, indirectly affects ERK pathway, which is involved in cell proliferation and differentiation, potentially intersecting with IGDCC4's signaling pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, modulates responses to stress, inflammation, and apoptosis, potentially affecting signaling pathways relevant to IGDCC4's function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, influences chromatin structure and gene expression, potentially affecting cellular processes where IGDCC4 is involved. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor, affects gene expression and differentiation, potentially modulating pathways related to IGDCC4's function in development. | ||||||